This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Heald, K. Articles by Downing, R. Search for Related Content Social Bookmarking                         What's this?

Human islet transplantation: expectation versus reality

Tessa Jay

Richard Downing

The Islet Research Laboratory, Worcestershire Clinical Research Unit, Worcestershire Acute Hospitals NHS Trust, Worcester Royal Infirmary, Newtown Road, Worcester, WR5 1HN, rd{at}isletlab.org.uk

Although experimental islet isolation and transplantation has continued for over 25 years, the results of human islet transplantation in patients with type 1 diabetes were disappointing until June 2000 when the University of Alberta, Edmonton, Canada reported 100% insulin independence in a cohort of seven patients. The study introduced several innovations now under evaluation worldwide. In the United Kingdom, an Islet Transplant Consortium has been established to co-ordinate clinical trials in several centres. The Canadian results have renewed hope of establishing islet transplantation as a treatment for diabetes while highlighting the need to identify plentiful sources of insulin secreting tissue and alternatives to current immunosuppressive therapies.

Key Words: islet transplantation • type 1 diabetes.

References

• Day C. The rising tide of type 2 diabetes. Br J Diabetes Vasc Dis 2001;1:37-43.[Abstract/Free Full Text]
• Onkano P., Vaananen S., Karvonen M., Tuomilehto J. Worldwide increase in incidence of type one diabetes - the analysis of the data on published incidents trends. Diabetologia 1999;42:1395-403.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.[Abstract/Free Full Text]
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nishimura R., LaPorte RE, Dorman JS, Tajima N., Becker D., Orchard TJ Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999. Diabetes Care 2001;24:823-7.[Abstract/Free Full Text]
• Sutherland DER, Gruessner RWG, Dunn DL et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 2001;233:463-501.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967;16:35-9.[Web of Science][Medline] [Order article via Infotrieve]
• Gray BN, Watkins E. Jr. Prevention of vascular complications of diabetes by pancreatic islet transplantation. Arch Surg 1976;111:254-7.[Abstract/Free Full Text]
• Linetsky E., Inveradi L., Kenyon NS, Alejandro R., Ricordi C. Endotoxin contamination of reagents used during isolation and purification of human pancreatic islets. Trans Proc 1988;30:345-6.
• Olack BJ, Swanson CJ, Howard TK, Mohanakumar T. Improved method for the isolation and purification of human islets of Langerhans using Liberase enzyme blend. Hum Immunol 1999;60:1303-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Linetsky E., Bottino R., Lehmann R., Alejandro R., Inveradi L., Ricordi C. Improved human islet isolation using a new enzyme blend, Liberase. Diabetes 1997;46:1120-3.[Abstract]
• Brendel MD, Hering BJ, Schultz AO, Bretzel RG International Islet Transplant Registry Newsletter (9) 2001;8:1-20.
• Bretzel RG, Brandhorst D., Brandhorst H. et al. Improved survival of intra-portal pancreatic islet cell allografts in patients with type 1 diabetes mellitus by refined peritransplant management. J Mol Med 1999;77:140-3.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Shapiro AMJ, Lakey JRT, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New Engl J Med 2000;343:230-8.[Abstract/Free Full Text]
• Ryan EA, Lakey JRT, Rajotte RV et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710-19.[Abstract/Free Full Text]
• Shapiro AMJ, Ryan EA, Paty B. et al. Update on clinical islet transplantation - Edmonton Protocol. Cell Trans 2001;10:518.
• Lakey JRT, Warnock GL, Ao Z. et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Trans Proc 1998;30:359.[CrossRef]
• A Code of Practice for Tissue Banks, Department of Health 2001.
• Assady S., Maor G., Amit M., Itskovitz-Eldor J., Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001;50:1691-7.[Abstract/Free Full Text]
• Berna G., Leon-Quinto T., Ensenat-Waser R., Montanya E., Martin F., Soria B. Stem cells and diabetes. Biomed Pharmacother 2001;55:206-12.[CrossRef][Medline] [Order article via Infotrieve]
• MacFarlane WM, Chapman JC, Shepherd RM et al. Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy. J Biol Chem 1999;274:34059-34066.[Abstract/Free Full Text]
• Cooper DK, Groth CG, McKenzie IF Xenotransplantation. This form of treatment might benefit millions. BMJ 2000;320:686.[Abstract/Free Full Text]
• Inveradi L., Ricordi C. Tolerance and pancreatic islet transplantation. Philos Trans R Soc Lond B Biol Sci 2001;356:759-65.[Abstract/Free Full Text]
• Mullen Y., Maruyama M., Smith CV Current progress and perspectives in immunoisolated islet transplantation. J Hepatobiliary Pancreat Surg 2000;7:347-57.[CrossRef][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 1, No. 2, 128-130 (2001)
DOI: 10.1177/14746514010010021201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Heald, K. Articles by Downing, R. Search for Related Content Social Bookmarking                         What's this?